NO932670D0 - Blandinger - Google Patents

Blandinger

Info

Publication number
NO932670D0
NO932670D0 NO932670A NO932670A NO932670D0 NO 932670 D0 NO932670 D0 NO 932670D0 NO 932670 A NO932670 A NO 932670A NO 932670 A NO932670 A NO 932670A NO 932670 D0 NO932670 D0 NO 932670D0
Authority
NO
Norway
Prior art keywords
mixtures
Prior art date
Application number
NO932670A
Other languages
English (en)
Other versions
NO932670L (no
Inventor
Joanne Craig
David Alistair Saynor
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO932670L publication Critical patent/NO932670L/no
Publication of NO932670D0 publication Critical patent/NO932670D0/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
NO932670A 1991-01-24 1993-07-23 Blandinger NO932670D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919102579A GB9102579D0 (en) 1991-01-24 1991-01-24 Compositions
PCT/EP1992/000094 WO1992012712A1 (en) 1991-01-24 1992-01-19 Compositions

Publications (2)

Publication Number Publication Date
NO932670L NO932670L (no) 1993-07-23
NO932670D0 true NO932670D0 (no) 1993-07-23

Family

ID=10689660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932670A NO932670D0 (no) 1991-01-24 1993-07-23 Blandinger

Country Status (8)

Country Link
US (1) US5393773A (no)
EP (1) EP0496308A1 (no)
JP (1) JPH06504991A (no)
AU (1) AU653986B2 (no)
CA (1) CA2100569A1 (no)
GB (1) GB9102579D0 (no)
NO (1) NO932670D0 (no)
WO (1) WO1992012712A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (ja) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc 水性薬理組成物
TWI243687B (en) * 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6132757A (en) * 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
DE10064950A1 (de) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropes Nasenspray
US6562838B2 (en) 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US20040219229A1 (en) * 2003-04-30 2004-11-04 Tim Clarot Migraine relief composition and methods of using and forming same
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
EP1765300A2 (en) * 2004-06-10 2007-03-28 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
US11337962B2 (en) 2009-09-25 2022-05-24 Upsher-Smith Laboratories, Llc Formulations comprising triptan compounds
US9211282B2 (en) 2009-09-25 2015-12-15 Dr. Reddy's Laboratories Ltd. Formulations comprising triptan compounds
ES2842523T3 (es) 2015-05-15 2021-07-14 Univ Michigan Regents Métodos y composiciones para el tratamiento de la artritis
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ,インコーポレイテッド 医薬組成物
CN110770138A (zh) * 2017-04-24 2020-02-07 乔舒亚·D·莱文 触变性宾厄姆塑性流体避孕方法
JP2021502361A (ja) 2017-11-07 2021-01-28 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 共有エピトープ−カルレティキュリン相互作用の小分子阻害薬及び使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
EP0187433B1 (en) * 1983-08-01 1990-12-27 Teijin Limited Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations

Also Published As

Publication number Publication date
WO1992012712A1 (en) 1992-08-06
AU1165292A (en) 1992-08-27
AU653986B2 (en) 1994-10-20
CA2100569A1 (en) 1992-07-25
GB9102579D0 (en) 1991-03-27
NO932670L (no) 1993-07-23
US5393773A (en) 1995-02-28
JPH06504991A (ja) 1994-06-09
EP0496308A1 (en) 1992-07-29

Similar Documents

Publication Publication Date Title
NO932670D0 (no) Blandinger
ATE137279T1 (de) Stoffauflauf
FI924967A (fi) Doerrhandtagskombination
ATA131391A (de) Reibring
ATA170491A (de) Mauerstein
ATA39792A (de) Maehwerk
ATE163916T1 (de) Ethyl-6-formyloxy-4-hexenoat
ATA67791A (de) Rollski
ATA9892A (de) Formstein
BR9201945A (pt) Filatorio
FI924017A (fi) Kvaevningssystem
BR7101338U (pt) Bule-chicara
BR7102423U (pt) Mic-lav
ATA235591A (de) Eluiergeraet
SE9103174D0 (sv) Taetningselement
ATA23591A (de) Muenzkassa
ATA90791A (de) Manchon
SE9101874D0 (sv) Maskrosfaellaren
SE9100012D0 (sv) Medicineringsbox
FI915596A (fi) Snoeplog
BR7100443U (pt) Vigier
BR7100567U (pt) Auto-transponder
BR7100738U (pt) Aerofolio
BR7100920U (pt) Kit-pipoqueira
FI914541A (fi) Armkonstruktion